2,870 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Meitav Investment House Ltd.

Meitav Investment House Ltd. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,870 shares of the company’s stock, valued at approximately $1,166,000.

Several other institutional investors have also added to or reduced their stakes in HCA. Capital World Investors boosted its holdings in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $131,527,000. Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the period. Swedbank AB purchased a new position in HCA Healthcare during the 1st quarter worth $95,882,000. Finally, TD Asset Management Inc grew its position in shares of HCA Healthcare by 30.4% during the 1st quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock worth $240,581,000 after buying an additional 168,093 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $359.12 on Thursday. HCA Healthcare, Inc. has a 52 week low of $223.73 and a 52 week high of $417.14. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market capitalization of $94.06 billion, a price-to-earnings ratio of 18.00, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The firm has a 50-day simple moving average of $394.11 and a 200-day simple moving average of $353.54.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Analyst Ratings Changes

Several equities research analysts have recently commented on HCA shares. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Royal Bank of Canada raised their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Barclays raised their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $379.11.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.